News and Announcements

GSK plans $30bn US investment as pharma faces tariff threat

By Frank Prenesti

Date: Wednesday 17 Sep 2025

(Sharecast News) - GSK has announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years, amid fears of tariffs being imposed on the pharma industry by US President Donald Trump, who is in the UK on a state visit.
The...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page